Global Single-Domain Heavy Chain Antibody Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Single-Domain Heavy Chain Antibody Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Single-Domain Heavy Chain Antibody Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 Natural Single-Domain Heavy Chain Antibody
  • 1.2.3 Recombinant Single-Domain Heavy Chain Antibody
• 1.3 Market by Application
  • 1.3.1 Global Single-Domain Heavy Chain Antibody Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Treatment
  • 1.3.3 Diagnosis
  • 1.3.4 Research
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Single-Domain Heavy Chain Antibody Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Single-Domain Heavy Chain Antibody Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Single-Domain Heavy Chain Antibody Revenue by Region (2020-2031)
  • 2.2.3 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Region (2020-2031)
• 2.3 Global Single-Domain Heavy Chain Antibody Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Single-Domain Heavy Chain Antibody Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Single-Domain Heavy Chain Antibody Sales by Region (2020-2031)
  • 2.4.3 Global Single-Domain Heavy Chain Antibody Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Single-Domain Heavy Chain Antibody Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Single-Domain Heavy Chain Antibody Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Single-Domain Heavy Chain Antibody in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Single-Domain Heavy Chain Antibody Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by Single-Domain Heavy Chain Antibody Revenue in 2024
• 3.3 Global Key Players of Single-Domain Heavy Chain Antibody, Industry Ranking, 2023 VS 2024
• 3.4 Global Single-Domain Heavy Chain Antibody Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Single-Domain Heavy Chain Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Product Offered and Application
• 3.8 Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global Single-Domain Heavy Chain Antibody Historical Sales by Type (2020-2025)
  • 4.1.2 Global Single-Domain Heavy Chain Antibody Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Single-Domain Heavy Chain Antibody Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Single-Domain Heavy Chain Antibody Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Single-Domain Heavy Chain Antibody Price by Type (2020-2025)
  • 4.3.2 Global Single-Domain Heavy Chain Antibody Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global Single-Domain Heavy Chain Antibody Historical Sales by Application (2020-2025)
  • 5.1.2 Global Single-Domain Heavy Chain Antibody Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Single-Domain Heavy Chain Antibody Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Single-Domain Heavy Chain Antibody Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Single-Domain Heavy Chain Antibody Price by Application (2020-2025)
  • 5.3.2 Global Single-Domain Heavy Chain Antibody Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Single-Domain Heavy Chain Antibody Sales by Type (2020-2031)
  • 6.1.2 US & Canada Single-Domain Heavy Chain Antibody Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Single-Domain Heavy Chain Antibody Sales by Application (2020-2031)
  • 6.2.2 US & Canada Single-Domain Heavy Chain Antibody Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Single-Domain Heavy Chain Antibody Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Single-Domain Heavy Chain Antibody Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Single-Domain Heavy Chain Antibody Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Single-Domain Heavy Chain Antibody Sales by Type (2020-2031)
  • 7.1.2 Europe Single-Domain Heavy Chain Antibody Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Single-Domain Heavy Chain Antibody Sales by Application (2020-2031)
  • 7.2.2 Europe Single-Domain Heavy Chain Antibody Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe Single-Domain Heavy Chain Antibody Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe Single-Domain Heavy Chain Antibody Sales by Country (2020-2031)
  • 7.3.3 Europe Single-Domain Heavy Chain Antibody Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China Single-Domain Heavy Chain Antibody Sales by Type (2020-2031)
  • 8.1.2 China Single-Domain Heavy Chain Antibody Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China Single-Domain Heavy Chain Antibody Sales by Application (2020-2031)
  • 8.2.2 China Single-Domain Heavy Chain Antibody Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia Single-Domain Heavy Chain Antibody Sales by Type (2020-2031)
  • 9.1.2 Asia Single-Domain Heavy Chain Antibody Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia Single-Domain Heavy Chain Antibody Sales by Application (2020-2031)
  • 9.2.2 Asia Single-Domain Heavy Chain Antibody Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia Single-Domain Heavy Chain Antibody Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia Single-Domain Heavy Chain Antibody Revenue by Region (2020-2031)
  • 9.3.3 Asia Single-Domain Heavy Chain Antibody Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Sino Biological
  • 11.1.1 Sino Biological Company Information
  • 11.1.2 Sino Biological Overview
  • 11.1.3 Sino Biological Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Sino Biological Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Sino Biological Recent Developments
• 11.2 GenScript
  • 11.2.1 GenScript Company Information
  • 11.2.2 GenScript Overview
  • 11.2.3 GenScript Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 GenScript Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 GenScript Recent Developments
• 11.3 Proteintech Group
  • 11.3.1 Proteintech Group Company Information
  • 11.3.2 Proteintech Group Overview
  • 11.3.3 Proteintech Group Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Proteintech Group Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Proteintech Group Recent Developments
• 11.4 Abiocenter
  • 11.4.1 Abiocenter Company Information
  • 11.4.2 Abiocenter Overview
  • 11.4.3 Abiocenter Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.4 Abiocenter Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Abiocenter Recent Developments
• 11.5 MerryBio
  • 11.5.1 MerryBio Company Information
  • 11.5.2 MerryBio Overview
  • 11.5.3 MerryBio Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.4 MerryBio Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 MerryBio Recent Developments
• 11.6 Pregene
  • 11.6.1 Pregene Company Information
  • 11.6.2 Pregene Overview
  • 11.6.3 Pregene Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.4 Pregene Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Pregene Recent Developments
• 11.7 Cusabio
  • 11.7.1 Cusabio Company Information
  • 11.7.2 Cusabio Overview
  • 11.7.3 Cusabio Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.4 Cusabio Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Cusabio Recent Developments
• 11.8 Biocytogen
  • 11.8.1 Biocytogen Company Information
  • 11.8.2 Biocytogen Overview
  • 11.8.3 Biocytogen Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.4 Biocytogen Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Biocytogen Recent Developments
• 11.9 Thermo Fisher Scientific
  • 11.9.1 Thermo Fisher Scientific Company Information
  • 11.9.2 Thermo Fisher Scientific Overview
  • 11.9.3 Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.4 Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Thermo Fisher Scientific Recent Developments
• 11.10 QVQuality
  • 11.10.1 QVQuality Company Information
  • 11.10.2 QVQuality Overview
  • 11.10.3 QVQuality Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.10.4 QVQuality Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 QVQuality Recent Developments
• 11.11 HUABIO
  • 11.11.1 HUABIO Company Information
  • 11.11.2 HUABIO Overview
  • 11.11.3 HUABIO Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.11.4 HUABIO Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 HUABIO Recent Developments
• 11.12 Jackson ImmunoResearch
  • 11.12.1 Jackson ImmunoResearch Company Information
  • 11.12.2 Jackson ImmunoResearch Overview
  • 11.12.3 Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.12.4 Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Jackson ImmunoResearch Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Single-Domain Heavy Chain Antibody Industry Chain Analysis
• 12.2 Single-Domain Heavy Chain Antibody Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Single-Domain Heavy Chain Antibody Production Mode & Process
• 12.4 Single-Domain Heavy Chain Antibody Sales and Marketing
  • 12.4.1 Single-Domain Heavy Chain Antibody Sales Channels
  • 12.4.2 Single-Domain Heavy Chain Antibody Distributors
• 12.5 Single-Domain Heavy Chain Antibody Customers

13 Single-Domain Heavy Chain Antibody Market Dynamics

• 13.1 Single-Domain Heavy Chain Antibody Industry Trends
• 13.2 Single-Domain Heavy Chain Antibody Market Drivers
• 13.3 Single-Domain Heavy Chain Antibody Market Challenges
• 13.4 Single-Domain Heavy Chain Antibody Market Restraints

14 Key Findings in the Global Single-Domain Heavy Chain Antibody Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Single-Domain Heavy Chain Antibody Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of Natural Single-Domain Heavy Chain Antibody

Table 3. Major Manufacturers of Recombinant Single-Domain Heavy Chain Antibody

Table 4. Global Single-Domain Heavy Chain Antibody Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 5. Global Single-Domain Heavy Chain Antibody Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 6. Global Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Revenue Market Share by Region (2020-2031)

Table 8. Global Single-Domain Heavy Chain Antibody Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 9. Global Single-Domain Heavy Chain Antibody Sales by Region (2020-2031) & (K Units)

Table 10. Global Sales Market Share by Region (2020-2031)

Table 11. Global Single-Domain Heavy Chain Antibody Sales by Manufacturers (2020-2025) & (K Units)

Table 12. Global Single-Domain Heavy Chain Antibody Sales Share by Manufacturers (2020-2025)

Table 13. Global Single-Domain Heavy Chain Antibody Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 14. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Manufacturers (2020-2025)

Table 15. Global Key Players of Single-Domain Heavy Chain Antibody, Industry Ranking, 2023 VS 2024 VS 2024

Table 16. Single-Domain Heavy Chain Antibody Price by Manufacturers (2020-2025) & (US$/Unit)

Table 17. Global Single-Domain Heavy Chain Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 18. Global Single-Domain Heavy Chain Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single-Domain Heavy Chain Antibody as of 2024)

Table 19. Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Manufacturing Base Distribution and Headquarters

Table 20. Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Product Offered and Application

Table 21. Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Single-Domain Heavy Chain Antibody Sales by Type (2020-2025) & (K Units)

Table 24. Global Single-Domain Heavy Chain Antibody Sales by Type (2026-2031) & (K Units)

Table 25. Global Sales Share by Type (2020-2031)

Table 26. Global Single-Domain Heavy Chain Antibody Revenue by Type (2020-2025) & (US$ Million)

Table 27. Global Single-Domain Heavy Chain Antibody Revenue by Type (2026-2031) & (US$ Million)

Table 28. Global Revenue Share by Type (2020-2031)

Table 29. Single-Domain Heavy Chain Antibody Price by Type (2020-2025) & (US$/Unit)

Table 30. Global Single-Domain Heavy Chain Antibody Price Forecast by Type (2026-2031) & (US$/Unit)

Table 31. Global Single-Domain Heavy Chain Antibody Sales by Application (2020-2025) & (K Units)

Table 32. Global Single-Domain Heavy Chain Antibody Sales by Application (2026-2031) & (K Units)

Table 33. Global Sales Share by Application (2020-2031)

Table 34. Global Single-Domain Heavy Chain Antibody Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Single-Domain Heavy Chain Antibody Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Revenue Share by Application (2020-2031)

Table 37. Single-Domain Heavy Chain Antibody Price by Application (2020-2025) & (US$/Unit)

Table 38. Global Single-Domain Heavy Chain Antibody Price Forecast by Application (2026-2031) & (US$/Unit)

Table 39. US & Canada Sales by Type (2020-2031) & (K Units)

Table 40. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 41. US & Canada Sales by Application (2020-2031) & (K Units)

Table 42. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 43. US & Canada Single-Domain Heavy Chain Antibody Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 45. US & Canada Sales by Country (2020-2031) & (K Units)

Table 46. Europe Sales by Type (2020-2031) & (K Units)

Table 47. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 48. Europe Sales by Application (2020-2031) & (K Units)

Table 49. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 50. Europe Single-Domain Heavy Chain Antibody Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 51. Europe Sales by Country (2020-2031) & (K Units)

Table 52. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 53. China Sales by Type (2020-2031) & (K Units)

Table 54. China Revenue by Type (2020-2031) & (US$ Million)

Table 55. China Sales by Application (2020-2031) & (K Units)

Table 56. China Revenue by Application (2020-2031) & (US$ Million)

Table 57. Asia Sales by Type (2020-2031) & (K Units)

Table 58. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 59. Asia Sales by Application (2020-2031) & (K Units)

Table 60. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 61. Asia Single-Domain Heavy Chain Antibody Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 62. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 63. Asia Sales by Region (2020-2031) & (K Units)

Table 64. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 65. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 66. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 67. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 68. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 69. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 70. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 71. Sino Biological Company Information

Table 72. Sino Biological Description and Major Businesses

Table 73. Sino Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 74. Sino Biological Product Model Numbers, Pictures, Descriptions and Specifications

Table 75. Sino Biological Recent Developments

Table 76. GenScript Company Information

Table 77. GenScript Description and Major Businesses

Table 78. GenScript Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 79. GenScript Product Model Numbers, Pictures, Descriptions and Specifications

Table 80. GenScript Recent Developments

Table 81. Proteintech Group Company Information

Table 82. Proteintech Group Description and Major Businesses

Table 83. Proteintech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 84. Proteintech Group Product Model Numbers, Pictures, Descriptions and Specifications

Table 85. Proteintech Group Recent Developments

Table 86. Abiocenter Company Information

Table 87. Abiocenter Description and Major Businesses

Table 88. Abiocenter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 89. Abiocenter Product Model Numbers, Pictures, Descriptions and Specifications

Table 90. Abiocenter Recent Developments

Table 91. MerryBio Company Information

Table 92. MerryBio Description and Major Businesses

Table 93. MerryBio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 94. MerryBio Product Model Numbers, Pictures, Descriptions and Specifications

Table 95. MerryBio Recent Developments

Table 96. Pregene Company Information

Table 97. Pregene Description and Major Businesses

Table 98. Pregene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Pregene Product Model Numbers, Pictures, Descriptions and Specifications

Table 100. Pregene Recent Developments

Table 101. Cusabio Company Information

Table 102. Cusabio Description and Major Businesses

Table 103. Cusabio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Cusabio Product Model Numbers, Pictures, Descriptions and Specifications

Table 105. Cusabio Recent Developments

Table 106. Biocytogen Company Information

Table 107. Biocytogen Description and Major Businesses

Table 108. Biocytogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Biocytogen Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. Biocytogen Recent Developments

Table 111. Thermo Fisher Scientific Company Information

Table 112. Thermo Fisher Scientific Description and Major Businesses

Table 113. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Thermo Fisher Scientific Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Thermo Fisher Scientific Recent Developments

Table 116. QVQuality Company Information

Table 117. QVQuality Description and Major Businesses

Table 118. QVQuality Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. QVQuality Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. QVQuality Recent Developments

Table 121. HUABIO Company Information

Table 122. HUABIO Description and Major Businesses

Table 123. HUABIO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. HUABIO Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. HUABIO Recent Developments

Table 126. Jackson ImmunoResearch Company Information

Table 127. Jackson ImmunoResearch Description and Major Businesses

Table 128. Jackson ImmunoResearch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Jackson ImmunoResearch Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Jackson ImmunoResearch Recent Developments

Table 131. Key Raw Materials Lists

Table 132. Raw Materials Key Suppliers Lists

Table 133. Distributors List

Table 134. Customers List

Table 135. Market Trends

Table 136. Market Drivers

Table 137. Market Challenges

Table 138. Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Single-Domain Heavy Chain Antibody Product Picture

Figure 2. Global Single-Domain Heavy Chain Antibody Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Single-Domain Heavy Chain Antibody Market Share by Type: 2024 & 2031

Figure 4. Natural Single-Domain Heavy Chain Antibody Product Picture

Figure 5. Recombinant Single-Domain Heavy Chain Antibody Product Picture

Figure 6. Global Single-Domain Heavy Chain Antibody Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Single-Domain Heavy Chain Antibody Market Share by Application: 2024 & 2031

Figure 8. Treatment

Figure 9. Diagnosis

Figure 10. Research

Figure 11. Single-Domain Heavy Chain Antibody Report Years Considered

Figure 12. Global Single-Domain Heavy Chain Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 14. Global Single-Domain Heavy Chain Antibody Revenue by Region (2020-2031) (US$ Million)

Figure 15. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 16. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Region (2020-2031)

Figure 17. Global Single-Domain Heavy Chain Antibody Sales (2020-2031) & (K Units)

Figure 18. Global Single-Domain Heavy Chain Antibody Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 19. Global Single-Domain Heavy Chain Antibody Sales Market Share by Region (2020-2031)

Figure 20. US & Canada Single-Domain Heavy Chain Antibody Sales YoY (2020-2031) & (K Units)

Figure 21. US & Canada Single-Domain Heavy Chain Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 22. Europe Single-Domain Heavy Chain Antibody Sales YoY (2020-2031) & (K Units)

Figure 23. Europe Single-Domain Heavy Chain Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 24. China Single-Domain Heavy Chain Antibody Sales YoY (2020-2031) & (K Units)

Figure 25. China Single-Domain Heavy Chain Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 26. Asia (excluding China) Single-Domain Heavy Chain Antibody Sales YoY (2020-2031) & (K Units)

Figure 27. Asia (excluding China) Single-Domain Heavy Chain Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Sales YoY (2020-2031) & (K Units)

Figure 29. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Global Single-Domain Heavy Chain Antibody Sales Share by Manufacturers (2024)

Figure 31. The Single-Domain Heavy Chain Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 32. Global Single-Domain Heavy Chain Antibody Revenue Share by Manufacturers (2024)

Figure 33. The Top 5 and 10 Largest Manufacturers of Single-Domain Heavy Chain Antibody in the World: Market Share by Single-Domain Heavy Chain Antibody Revenue in 2024

Figure 34. Global Single-Domain Heavy Chain Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 35. Global Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)

Figure 36. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)

Figure 37. Global Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)

Figure 38. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)

Figure 39. US & Canada Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)

Figure 40. US & Canada Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)

Figure 41. US & Canada Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)

Figure 42. US & Canada Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)

Figure 43. US & Canada Single-Domain Heavy Chain Antibody Revenue Share by Country (2020-2031)

Figure 44. US & Canada Single-Domain Heavy Chain Antibody Sales Share by Country (2020-2031)

Figure 45. US Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)

Figure 48. Europe Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)

Figure 49. Europe Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)

Figure 50. Europe Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)

Figure 51. Europe Single-Domain Heavy Chain Antibody Sales Share by Country (2020-2031)

Figure 52. Europe Single-Domain Heavy Chain Antibody Revenue Share by Country (2020-2031)

Figure 53. Germany Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 54. France Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 58. China Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)

Figure 59. China Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)

Figure 60. China Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)

Figure 61. China Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)

Figure 62. Asia Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)

Figure 63. Asia Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)

Figure 64. Asia Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)

Figure 65. Asia Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)

Figure 66. Asia Single-Domain Heavy Chain Antibody Revenue Share by Region (2020-2031)

Figure 67. Asia Single-Domain Heavy Chain Antibody Sales Share by Region (2020-2031)

Figure 68. Japan Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 71. Southeast Asia Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 72. India Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 73. Australia Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)

Figure 75. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)

Figure 76. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)

Figure 77. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)

Figure 78. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Revenue Share by Country (2020-2031)

Figure 79. Middle East, Africa and Latin America Single-Domain Heavy Chain Antibody Sales Share by Country (2020-2031)

Figure 80. Brazil Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 81. Mexico Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 82. Turkey Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 83. Israel Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 84. GCC Countries Single-Domain Heavy Chain Antibody Revenue (2020-2031) & (US$ Million)

Figure 85. Value Chain

Figure 86. Single-Domain Heavy Chain Antibody Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed